DIABETIC KETOACIDOSIS

This adverse event was reported 20347 times

These drugs are most commonly taken by patients reporting DIABETIC KETOACIDOSIS:

# Drug Count
0 METFORMIN 3512
1 CANAGLIFLOZIN 3379
2 EMPAGLIFLOZIN 3249
3 METFORMIN ER 500 MG 3129
4 METFORMIN ER 750 MG 3129
5 INSULIN GLARGINE 2301
6 INSULIN LISPRO 1573
7 QUETIAPINE 1393
8 DAPAGLIFLOZIN 1270
9 INSULIN ASPART 1213
See all common drugs associated with DIABETIC KETOACIDOSIS

DIABETIC KETOACIDOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CANAGLIFLOZIN 3379 0.1183
1 CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 163 0.0934
2 ERTUGLIFLOZIN AND METFORMIN HYDROCHLORIDE 6 0.0845
3 EMPAGLIFLOZIN AND LINAGLIPTIN 139 0.0823
4 EMPAGLIFLOZIN 3249 0.0773
5 EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 135 0.0669
6 EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE 165 0.0658
7 DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 156 0.0623
8 INSULIN ASPART INJECTION 78 0.0486
9 DAPAGLIFLOZIN 1270 0.0486
See all drugs enriched for association with DIABETIC KETOACIDOSIS